Bill Stimson

Bill is the founder of the Department of Immunology at The University of Strathclyde. He has been involved in eight start-up/spin-out biotech companies. He has also been a long-term consultant to five multinational companies including Akzo Nobel (Organon), Rhone-Poulenc, Johnson & Johnson and Viragen Inc. Bill has published 216 scientific papers and 75 patents. He was involved in the use of the first human monoclonal antibodies for cancer therapy.